Search research articles
Contact Us
Filters
Showing results (31-40 of 60) with videos related to
Page
of 6
Sort By:
HIV Medicine
|
October 6, 2024
Bictegravir/emtricitabine/tenofovir alafenamide in adults with HIV-1 and end-stage kidney disease on chronic haemodialysis
Joseph J Eron, Moti Ramgopal, Olayemi Osiyemi, et al.
AIDS Research and Human Retroviruses
|
June 21, 2013
Clinical and pharmacogenetic factors affecting neonatal bilirubinemia following atazanavir treatment of mothers during pregnancy
Timothy Eley, Shu-Pang Huang, Francesca Conradie, et al.
Plos One
|
February 23, 2021
Clonal diversity and spatial dissemination of multi-antibiotics resistant Staphylococcus aureus pathotypes in Southwest Nigeria
Akinniyi Paul Akinduti, Joshua Adekunle Osiyemi, Temitope Temitayo Banjo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 26, 2015
Brief Report: Switch to Ritonavir-Boosted Atazanavir Plus Raltegravir in Virologically Suppressed Patients With HIV-1 Infection: A Randomized Pilot Study
Jan van Lunzen, Anton Pozniak, Jose M Gatell, et al.
HIV Medicine
|
May 18, 2016
Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women
H M Crauwels, T N Kakuda, B Ryan, et al.
HIV Medicine
|
May 17, 2011
Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women
F Conradie, C Zorrilla, D Josipovic, et al.
African Journal of Medicine and Medical Sciences
|
August 6, 2013
Inhibitory activities of selected south west Nigerian medicinal plants against mycobacterium tuberculosis
E O Ajaiyeoba, S I B Cadmus, O A Osiyemi, et al.
HIV Medicine
|
June 5, 2013
Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily
C D Zorrilla, R Wright, O O Osiyemi, et al.
Cureus
|
December 29, 2021
Determinants for Acceptance of COVID-19 Vaccine in Nigeria
Ugochukwu A Eze, Kingsley I Ndoh, Babalola A Ibisola, et al.
Open Forum Infectious Diseases
|
May 2, 2022
Ibrutinib for Hospitalized Adults With Severe Coronavirus Disease 2019 Infection: Results of the Randomized, Double-Blind, Placebo-Controlled iNSPIRE Study
Steven E Coutre, Christopher Barnett, Olayemi Osiyemi, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 60) with videos related to
Sort By:
Page
of 6
HIV Medicine
|
October 6, 2024
Bictegravir/emtricitabine/tenofovir alafenamide in adults with HIV-1 and end-stage kidney disease on chronic haemodialysis
Joseph J Eron, Moti Ramgopal, Olayemi Osiyemi, et al.
AIDS Research and Human Retroviruses
|
June 21, 2013
Clinical and pharmacogenetic factors affecting neonatal bilirubinemia following atazanavir treatment of mothers during pregnancy
Timothy Eley, Shu-Pang Huang, Francesca Conradie, et al.
Plos One
|
February 23, 2021
Clonal diversity and spatial dissemination of multi-antibiotics resistant Staphylococcus aureus pathotypes in Southwest Nigeria
Akinniyi Paul Akinduti, Joshua Adekunle Osiyemi, Temitope Temitayo Banjo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 26, 2015
Brief Report: Switch to Ritonavir-Boosted Atazanavir Plus Raltegravir in Virologically Suppressed Patients With HIV-1 Infection: A Randomized Pilot Study
Jan van Lunzen, Anton Pozniak, Jose M Gatell, et al.
HIV Medicine
|
May 18, 2016
Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women
H M Crauwels, T N Kakuda, B Ryan, et al.
HIV Medicine
|
May 17, 2011
Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women
F Conradie, C Zorrilla, D Josipovic, et al.
African Journal of Medicine and Medical Sciences
|
August 6, 2013
Inhibitory activities of selected south west Nigerian medicinal plants against mycobacterium tuberculosis
E O Ajaiyeoba, S I B Cadmus, O A Osiyemi, et al.
HIV Medicine
|
June 5, 2013
Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily
C D Zorrilla, R Wright, O O Osiyemi, et al.
Cureus
|
December 29, 2021
Determinants for Acceptance of COVID-19 Vaccine in Nigeria
Ugochukwu A Eze, Kingsley I Ndoh, Babalola A Ibisola, et al.
Open Forum Infectious Diseases
|
May 2, 2022
Ibrutinib for Hospitalized Adults With Severe Coronavirus Disease 2019 Infection: Results of the Randomized, Double-Blind, Placebo-Controlled iNSPIRE Study
Steven E Coutre, Christopher Barnett, Olayemi Osiyemi, et al.
Page
of 6